Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
EMA Reviewing Cardiovascular & Cancer Risk From Five Janus Kinase Inhibitors
Feb 14 2022
•
By
Neena Brizmohun
A review into the safety of five JAK inhibitors has started • Source: Alamy
More from Drug Safety
More from Pink Sheet